ScienceEnveda secures $311M to bring more nature-derived AI drugs into clinical trials
AI biotech company Enveda has raised $311 million in a round that values it at $2 billion. It is currently testing drugs for skin conditions and treatments intended to preserve weight loss after people stop taking GLP-1s.
T
TechCrunch★★☆☆☆2026-09-23 19:31Original
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Science